Comment
doi: 10.1016/j.atherosclerosis.2021.02.001.
Epub 2021 Feb 6.
Benefits and harms of LDL-cholesterol-lowering therapy in older people must be established through valid and clinically relevant evidence
Affiliations
- PMID: 33589133
- DOI: 10.1016/j.atherosclerosis.2021.02.001
Item in Clipboard
Comment
Benefits and harms of LDL-cholesterol-lowering therapy in older people must be established through valid and clinically relevant evidence
Atherosclerosis.
2021 Apr.
No abstract available
Keywords: Lipid-modifying drugs; Meta-analysis; Older people.
Comment in
-
Reply to: "It's time to stop the nonsense of withholding lipid lowering therapy on account of age" and "The evidence around safe and effective LDL cholesterol-lowering therapy in elderly individuals demands validity and clinical relevance".Atherosclerosis. 2021 Apr;323:59-60. doi: 10.1016/j.atherosclerosis.2021.03.005. Epub 2021 Mar 15. Atherosclerosis. 2021. PMID: 33762114 No abstract available.
Comment on
-
Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials.Lancet. 2020 Nov 21;396(10263):1637-1643. doi: 10.1016/S0140-6736(20)32332-1. Epub 2020 Nov 10. Lancet. 2020. PMID: 33186535 Free PMC article.
-
Should we treat high LDL cholesterol in 'healthy' elderly individuals?Atherosclerosis. 2021 Jan;317:50-51. doi: 10.1016/j.atherosclerosis.2020.11.029. Epub 2020 Dec 4. Atherosclerosis. 2021. PMID: 33334551 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
